Display options
Share it on

Front Psychiatry. 2020 May 20;11:380. doi: 10.3389/fpsyt.2020.00380. eCollection 2020.

Depression in the Elderly. Consensus Statement of the Spanish Psychogeriatric Association.

Frontiers in psychiatry

Luis Agüera-Ortiz, María Dolores Claver-Martín, María Dolores Franco-Fernández, Jorge López-Álvarez, Manuel Martín-Carrasco, María Isabel Ramos-García, Manuel Sánchez-Pérez

Affiliations

  1. Servicio de Psiquiatría, Instituto de Investigación i+12, Hospital Universitario 12 de Octubre, Madrid, Spain.
  2. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
  3. Madrid Salud, Ayuntamiento de Madrid, Madrid, Spain.
  4. Psychiatry Department, University of Sevilla, Seville, Spain.
  5. FIDMAG Research Foundation (CIBERSAM), Barcelona, Spain.
  6. Instituto de Psiquiatría y Salud Mental, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
  7. Unidad de Psiquiatría Geriátrica, Hospital Sagrat Cor. Martorell, Barcelona, Spain.

PMID: 32508684 PMCID: PMC7251154 DOI: 10.3389/fpsyt.2020.00380

Abstract

INTRODUCTION: Present knowledge about depression in the elderly is still scarce and often controversial, despite its high frequency and impact. This article reports the results and most relevant conclusions of a Delphi-based consensus on geriatric depression promoted by the Spanish Psychogeriatric Association.

METHODS: A 78-item questionnaire was developed by 7 highly specialized geriatric psychiatrists and was evaluated using the Modified Delphi technique in two rounds answered by 35 psychiatrists with an extensive expertise in geriatric depression. The topics and number of questions (in brackets) covered were: concepts, clinical aspects, and risk factors (12); screening and diagnosis (7); psychotic depression (17); depression and dementia (5); antidepressant drug treatment (18); non-pharmacological biological treatments (5); psychotherapeutic treatments (4); comorbidity and preventive aspects (6); professional training needed (4). In addition, the expert panel's opinion on the antidepressants of choice in 21 common comorbid conditions and on different strategies to approach treatment-resistant cases in terms of both efficacy and safety was assessed.

RESULTS: After the two rounds of the Delphi process, consensus was reached for 59 (75.6%) of the 78 items. Detailed recommendations are included in the text. Considering pharmacological treatments, agomelatine was the most widely mentioned drug to be recommended in terms of safety in comorbid conditions. Desvenlafaxine, sertraline, and vortioxetine, were the most frequently recommended antidepressants in comorbid conditions in general. Combining parameters of efficacy and safety, experts recommended the following steps to address cases of treatment resistance: 1. Escalation to the maximum tolerated dose; 2. Change of antidepressant; 3. Combination with another antidepressant; 4. Potentiation with an antipsychotic or with lamotrigine; 5. Potentiation with lithium; 6. Potentiation with dopamine agonists or methylphenidate.

DISCUSSION AND CONCLUSIONS: Consensus was reached for a high number of items as well as for the management of depression in the context of comorbid conditions and in resistant cases. In the current absence of sufficient evidence-based information, our results can be used to inform medical doctors about clinical recommendations that might reduce uncertainty in the diagnosis and treatment of elderly patients with depressive disorders.

Copyright © 2020 Agüera-Ortiz, Claver-Martín, Franco-Fernández, López-Álvarez, Martín-Carrasco, Ramos-García and Sánchez-Pérez.

Keywords: antidepressant drugs; clinical recommendations; comorbidity; consensus statement; depression; elderly; treatment-resistance

References

  1. Actas Esp Psiquiatr. 2011 Jan-Feb;39(1):20-31 - PubMed
  2. Am J Geriatr Psychiatry. 2012 Jan;20(1):5-17 - PubMed
  3. J ECT. 2013 Jun;29(2):106-8 - PubMed
  4. Rev Psiquiatr Salud Ment. 2014 Oct-Dec;7(4):195-207 - PubMed
  5. JAMA. 2017 May 23;317(20):2114-2122 - PubMed
  6. Int Psychogeriatr. 2017 Nov;29(11):1801-1824 - PubMed
  7. J Affect Disord. 2014 Oct;168:276-83 - PubMed
  8. J Health Serv Res Policy. 2006 Oct;11(4):218-24 - PubMed
  9. Int J Geriatr Psychiatry. 2003 Aug;18(8):694-9 - PubMed
  10. Int J Geriatr Psychiatry. 2016 Apr;31(4):412-20 - PubMed
  11. Psychol Med. 2019 Jan;49(2):232-242 - PubMed
  12. BMC Med. 2016 Nov 3;14(1):161 - PubMed
  13. Clin Geriatr Med. 2014 Aug;30(3):517-34 - PubMed
  14. Am J Psychiatry. 2000 Mar;157(3):351-9 - PubMed
  15. J Clin Psychiatry. 2011 Jan;72(1):e04 - PubMed
  16. JAMA. 1997 Oct 8;278(14):1186-90 - PubMed
  17. Lancet. 2015 Aug 22;386(9995):743-800 - PubMed
  18. Int Psychogeriatr. 2017 May;29(5):717-726 - PubMed
  19. Convuls Ther. 1993;9(1):39-42 - PubMed
  20. J Affect Disord. 2010 Jun;123(1-3):222-9 - PubMed
  21. Int J Geriatr Psychiatry. 2006 Dec;21(12):1139-49 - PubMed
  22. Oncologist. 2009 Jan;14(1):60-6 - PubMed
  23. Arch Gen Psychiatry. 2010 Mar;67(3):277-85 - PubMed
  24. Int J Geriatr Psychiatry. 2008 Sep;23(9):915-21 - PubMed
  25. JAMA. 2001 Mar 14;285(10):1299-307 - PubMed
  26. Med J Aust. 2005 Jun 20;182(12):627-32 - PubMed
  27. Aten Primaria. 2020 Apr;52(4):224-232 - PubMed
  28. J Neuropsychiatry Clin Neurosci. 1992 Spring;4(2):140-4 - PubMed
  29. JAMA Psychiatry. 2017 Jul 1;74(7):673-674 - PubMed
  30. Am J Geriatr Psychiatry. 2017 Oct;25(10):1135-1149 - PubMed
  31. Am J Psychiatry. 2005 Apr;162(4):711-7 - PubMed
  32. Am J Geriatr Psychiatry. 2010 May;18(5):442-51 - PubMed
  33. Am J Geriatr Psychiatry. 2018 Jan;26(1):107-122 - PubMed
  34. J Affect Disord. 2009 Oct;117 Suppl 1:S15-25 - PubMed
  35. Fam Pract. 2006 Jun;23(3):369-77 - PubMed
  36. J Affect Disord. 2015 Jul 1;179:6-13 - PubMed
  37. Neuropsychiatr Dis Treat. 2016 Aug 24;12:2105-14 - PubMed
  38. J Psychiatr Res. 2016 Jun;77:42-51 - PubMed
  39. J Psychiatr Res. 2016 Nov;82:1-7 - PubMed
  40. Alzheimers Dement. 2017 Jan;13(1):59-71 - PubMed
  41. Maturitas. 2014 Oct;79(2):147-52 - PubMed
  42. Am J Psychiatry. 1999 Dec;156(12):1865-70 - PubMed
  43. Am J Psychiatry. 2011 Jul;168(7):681-8 - PubMed
  44. Int J Geriatr Psychiatry. 2007 Feb;22(2):101-5 - PubMed
  45. Crisis. 2016 Mar;37(2):161-5 - PubMed
  46. Med Clin North Am. 2017 Jul;101(4):807-821 - PubMed
  47. Am J Psychiatry. 1998 Feb;155(2):178-83 - PubMed
  48. J Gerontol Nurs. 2018 Mar 1;44(3):31-38 - PubMed
  49. J Clin Psychiatry. 2019 Mar 19;80(2): - PubMed
  50. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004853 - PubMed
  51. Arq Neuropsiquiatr. 2012 Aug;70(8):617-20 - PubMed
  52. Int J Geriatr Psychiatry. 2015 Mar;30(3):265-73 - PubMed
  53. J Neurol. 2019 Aug 14;: - PubMed
  54. J Affect Disord. 2013 Sep 5;150(2):161-70 - PubMed
  55. Int J Geriatr Psychiatry. 2003 Aug;18(8):686-93 - PubMed
  56. Am J Psychiatry. 2006 Sep;163(9):1493-501 - PubMed
  57. Curr Neuropharmacol. 2015;13(5):577-91 - PubMed
  58. Metabolism. 2005 May;54(5 Suppl 1):39-44 - PubMed
  59. Am J Psychiatry. 2000 Apr;157(4 Suppl):1-45 - PubMed
  60. JAMA. 2012 Sep 5;308(9):909-18 - PubMed
  61. J Affect Disord. 2017 Oct 15;221:123-131 - PubMed
  62. Maturitas. 2014 Oct;79(2):184-90 - PubMed
  63. Am J Geriatr Psychiatry. 2008 Jun;16(6):498-505 - PubMed
  64. J Clin Psychiatry. 2018 Jul 31;79(5): - PubMed
  65. Br J Psychiatry. 2015 Jan;206(1):67-71 - PubMed
  66. PLoS One. 2011;6(6):e20476 - PubMed
  67. Eur Neuropsychopharmacol. 2011 Sep;21(9):655-79 - PubMed
  68. Convuls Ther. 1986;2(1):7-17 - PubMed
  69. Int J Geriatr Psychiatry. 2014 Aug;29(8):789-96 - PubMed
  70. Indian J Psychiatry. 2018 Feb;60(Suppl 3):S341-S362 - PubMed
  71. Can J Psychiatry. 2016 Sep;61(9):588-603 - PubMed
  72. Am J Geriatr Psychiatry. 2013 Oct;21(10):973-86 - PubMed
  73. Clin Ther. 2009 May;31(5):945-61 - PubMed
  74. Br Med J (Clin Res Ed). 1986 May 24;292(6532):1365-7 - PubMed
  75. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Aug 1;78:27-33 - PubMed
  76. Am J Geriatr Psychiatry. 2015 Mar;23(3):261-73 - PubMed
  77. Psychother Psychosom. 2010;79(5):285-94 - PubMed
  78. J Neurol Neurosurg Psychiatry. 2011 Aug;82(8):914-23 - PubMed
  79. Am J Geriatr Psychiatry. 2019 Oct;27(10):1138-1152 - PubMed
  80. J Neuropsychiatry Clin Neurosci. 2004 Fall;16(4):465-71 - PubMed
  81. J Affect Disord. 1991 Jul;22(3):135-48 - PubMed
  82. Handb Clin Neurol. 2019;167:429-435 - PubMed
  83. Psychiatr Clin North Am. 2013 Dec;36(4):483-96 - PubMed
  84. Curr Psychiatry Rep. 2016 Apr;18(4):40 - PubMed
  85. J Am Geriatr Soc. 2015 May;63(5):1002-9 - PubMed
  86. J Affect Disord. 2008 Jul;109(1-2):193-7 - PubMed
  87. Curr Psychiatry Rep. 2014 Aug;16(8):456 - PubMed
  88. N Engl J Med. 2014 Sep 25;371(13):1228-36 - PubMed
  89. Neurology. 2009 Mar 10;72(10):886-92 - PubMed
  90. Mol Psychiatry. 2018 Aug 31;: - PubMed
  91. Psychol Med. 2019 Feb;49(3):353-365 - PubMed
  92. Am J Geriatr Psychiatry. 2016 Oct;24(10):913-7 - PubMed
  93. Rev Psiquiatr Salud Ment. 2018 Oct - Dec;11(4):216-226 - PubMed
  94. Crisis. 2011;32(2):88-98 - PubMed
  95. Br J Psychiatry. 2010 Mar;196(3):226-34 - PubMed
  96. Arch Gen Psychiatry. 2011 Jan;68(1):33-41 - PubMed
  97. J Alzheimers Dis. 2010;20(1):175-83 - PubMed
  98. Int J Geriatr Psychiatry. 2016 May;31(5):526-35 - PubMed

Publication Types